David O. Watson

General Counsel

David O. Watson (General Counsel) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in APLS. The largest single filing was $171K of APLS (7,832 sh × $21.77, as filed), executed Jan 22.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$648K

shares × price, as filed

Last traded

Jan 22

Filed Jan 23

Open performance→

Volume by month

Buys $0 Sells $2.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 5 filings

Sector per market data · by filing · past 12 months

Most traded names

APLS APLS APLS · 0 buys · 12 sells 12 filings

Recent filings

APLSSALE Apellis Pharmaceuticals, Inc. View filing → $171K
7,832 sh × $21.77
Exec Jan 22
Filed Jan 23 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $128K
5,780 sh × $22.19
Exec Jan 13
Filed Jan 15 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $122K
5,000 sh × $24.49
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $100K
5,000 sh × $20.06
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $126K
5,000 sh × $25.22
Exec Oct 16 2025
Filed Oct 17 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $122K
5,000 sh × $24.34
Exec Sep 16 2025
Filed Sep 18 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $523K
20,000 sh × $26.17
Exec Sep 10 2025
Filed Sep 12 2025 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. View filing → $139K
5,000 sh × $27.80
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET More filings →